Switch Language

Radiology Insider

Bayer Logo
Radiology insider

Radiology
Insider

Bayer Logo

The latest updates in Radiology

All you need to know about best practices in Canadian diagnostic imaging, improvements in patient care, and successes in increasing throughput for MRI and CT exams. Click here to subscribe today.

Radiology Insider Articles

Optimized Protocols for Breast MRI – Increasing the total number of breast MRI screening exams in Canada

Optimized Protocols for Breast MRI – Increasing the total number of breast MRI screening exams in Canada

Optimized Protocols for Breast MRI – Increasing the total number of breast MRI screening exams in Canada


 The pandemic has exacerbated the backlog in breast imaging and the longer patients wait to get screened, the more likely the cancer is going to be diagnosed at a later stage, leading to more aggressive treatment options. The Ottawa Hospital ran a 10-month trial with optimized protocols for breast imaging that aimed to bring the average scan times from 30 minutes to 12 minutes. Click here to learn more about optimized protocols for breast imaging.

Read more
RI July BOP article RI July BOP article

The current liver imaging landscape in Canada: from CT to Primovist®-enhanced MRI

The current liver imaging landscape in Canada: from CT to Primovist®-enhanced MRI

The current liver imaging landscape in Canada: from CT to Primovist®-enhanced MRI


Bayer continues to seek out ways to best support liver imaging practices and optimize patient outcomes. For that reason, we recently conducted a survey across Canada to gain a better understanding of the current liver imaging landscape directly from clinics and healthcare professionals – such as yourself.

The survey explored topics such as the different modalities currently being used for liver imaging, reasons for using Primovist®-enhanced MRI, sites current and desired usage of Primovist among different focal liver lesions, potential factors that can affect the use of Primovist, and the top referring physicians involved.

Read more
RI July Primovist survey article RI July Primovist survey article

DENSE Trial Second Round Results

DENSE Trial Second Round Results

DENSE Trial Second Round Results


Results from the second round of the DENSE trial were published in the May 2021 issue of Radiology1. The DENSE trial is a multicenter, randomized controlled trial in the Netherlands and has enrolled 40,373 women between the ages of 50 and 75 years with extremely dense breast tissue and previous normal results on a mammogram. Dr. Carla van Gils presents results from the second round in this video.

Read more
vg.jpg vg.jpg